Please Wait
Applying Filters...
menu
    • menu
    Towa Pharmaceutical-PSE
    News
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    FY2024 Supplementary Material of Financial Results 1Q

    08 Aug 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Towa Pharmaceutical

    Contact Supplier

    Website

    American Pharma Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/prL_A0I4ZVQ
    Menu

    Towa Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/towa-pharmaceutical-party-content-2847.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of October 23, 2024
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf

    FDA
    23 Oct 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    FY2024 Supplementary Material of Financial Results 1Q
    FY2024 Supplementary Material of Financial Results 1Q

    08 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/slide69a.pdf

    PRESS RELEASE
    08 Aug 2024
    Share Share
    Notice of Financial Results of Parent Company, etc.
    Notice of Financial Results of Parent Company, etc.

    25 Jun 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240625_4.pdf

    PRESS RELEASE
    25 Jun 2024
    Share Share
    NHI Drug Price List Updated With Three Ingredients & 7 Generics
    NHI Drug Price List Updated With Three Ingredients & 7 Generics

    13 Jun 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240613.pdf

    PRESS RELEASE
    13 Jun 2024
    Share Share
    Summary of Consolidated Financial Results for the Year Ended March 31, 2024
    Summary of Consolidated Financial Results for the Year Ended March 31, 2024

    14 May 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/assets/result68d.pdf

    PRESS RELEASE
    14 May 2024
    Share Share